Oaktree Acquisition Corp. III Life Sciences

Oaktree Acquisition Corp. III Life Sciences (Nasdaq: OACC) is a blank-check company sponsored by an affiliate of Oaktree Capital Management, L.P., the Los Angeles-based alternative investment firm. The vehicle is the third SPAC in Oaktree's acquisition-company series and is focused exclusively on the life sciences sector, targeting businesses across biotechnology, pharmaceuticals, medical devices, and related healthcare subsectors. OACC went public in 2025 and remains in its search phase, as reflected by the 10-Q quarterly report filed with the SEC on August 12, 2026 under accession number 0001193125-26-346973. Oaktree's prior SPACs include the original Oaktree Acquisition Corp., which completed a business combination with Hims & Hers Health in 2021. Sign up on SpacDesk for full filings history, deal-stage tracking, and real-time data on OACC and hundreds of other active SPACs.